reference/18939563

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18939563

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase III\|Journal Article\|Multicenter Study\|Randomized Controlled Trial
endingPage	162
issn	1744-2818 1350-6129
issueIdentifier	3
pageRange	153-162
publicationName	Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
startingPage	153
bibliographicCitation	Obici L, Berk JL, González-Duarte A, Coelho T, Gillmore J, Schmidt HH, Schilling M, Yamashita T, Labeyrie C, Brannagan TH, Ajroud-Driss S, Gorevic P, Kristen AV, Franklin J, Chen J, Sweetser MT, Wang JJ, Adams D. Quality of life outcomes in APOLLO, the phase 3 trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis. Amyloid. 2020 Sep;27(3):153–62. doi: 10.1080/13506129.2020.1730790. PMID: 32131641.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7657-3700 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dc650a9d22d573b915831e241fb21807 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_769cace64695ea597b7bc0d27c3688e0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_525439a3aa9106bdc06610491446386e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f99c6cf633d6279b72a7ddf1afcb6d1f http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1768-2373 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c64f2887a5d4ddd6a0ff811cbaf0ede5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ef40e81d01700b1cc47d9bfc6e0ddaed http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f2f0d6ac19283df491013075d0e602c2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fc42893081887d88682d6b5302c77c35 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c0e6795e514182ecbd7e8edf4c57909d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b57a86ae1da6fc5ee6c6102e0d9eb2a7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_88a231c45c7176c7f9dda917eb2f2c05 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_442300849032b9475238bd499dd5aa95 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eb6a72ad4fcd6fe53305f2d0fd2ae1dc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c7d0ed6a28ce812189fd9c9cfc3484de http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_926398deea32047cca8165ebe37a8bb9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_beb5f0e950c6906622c998cb6403958b
date	2020-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/32131641 https://doi.org/10.1080/13506129.2020.1730790
isPartOf	https://portal.issn.org/resource/ISSN/1744-2818 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/20942 https://portal.issn.org/resource/ISSN/1350-6129
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Quality of life outcomes in APOLLO, the phase 3 trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis
discusses	http://id.nlm.nih.gov/mesh/C567782 http://id.nlm.nih.gov/mesh/M000647713 http://id.nlm.nih.gov/mesh/M000617065 http://id.nlm.nih.gov/mesh/M0017446 http://id.nlm.nih.gov/mesh/M0406100
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D034741Q000008 http://id.nlm.nih.gov/mesh/D011115Q000188 http://id.nlm.nih.gov/mesh/D028227Q000188 http://id.nlm.nih.gov/mesh/D011228Q000235
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D015990 http://id.nlm.nih.gov/mesh/D011115Q000150 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D011788 http://id.nlm.nih.gov/mesh/D028227Q000235 http://id.nlm.nih.gov/mesh/D011115Q000473 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D028227Q000473 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D009154Q000187 http://id.nlm.nih.gov/mesh/D011115Q000235 http://id.nlm.nih.gov/mesh/D055815 http://id.nlm.nih.gov/mesh/D000293 http://id.nlm.nih.gov/mesh/D028227Q000150 http://id.nlm.nih.gov/mesh/D000328
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6864 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_da1ca8f34cf9fa260557c3847aa16ec1 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8936 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7448

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7276

Total number of triples: 69.